Gastroparesis News and Research

RSS
Gastroparesis, also called delayed gastric emptying, is a disorder in which the stomach takes too long to empty its contents. Normally, the stomach contracts to move food down into the small intestine for digestion. The vagus nerve controls the movement of food from the stomach through the digestive tract. Gastroparesis occurs when the vagus nerve is damaged and the muscles of the stomach and intestines do not work normally. Food then moves slowly or stops moving through the digestive tract.
Antidepressant nortriptyline does not improve overall symptoms in patients with idiopathic gastroparesis

Antidepressant nortriptyline does not improve overall symptoms in patients with idiopathic gastroparesis

Targacept reports top-line results from TC-5619 Phase 2b trial for negative symptoms in schizophrenia

Targacept reports top-line results from TC-5619 Phase 2b trial for negative symptoms in schizophrenia

Dietary modifications can reduce gastroparesis in diabetes patients

Dietary modifications can reduce gastroparesis in diabetes patients

Rhythm starts RM-493 clinical trials in obesity patients with genetic deficiency

Rhythm starts RM-493 clinical trials in obesity patients with genetic deficiency

MJFF awards $1.35M to Rhythm for Phase 2 clinical trial of RM-131 for Parkinson's disease

MJFF awards $1.35M to Rhythm for Phase 2 clinical trial of RM-131 for Parkinson's disease

New endoscopic technique reduces symptoms in gastroparesis patients

New endoscopic technique reduces symptoms in gastroparesis patients

Research highlights benefits of vitamin D, diet changes in patients with Crohn's disease

Research highlights benefits of vitamin D, diet changes in patients with Crohn's disease

AGA researchers to present exciting data on GI disorders at DDW 2013

AGA researchers to present exciting data on GI disorders at DDW 2013

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Orphan, St George's sign licensing agreement to develop new therapies for metabolic disorders

Orphan, St George's sign licensing agreement to develop new therapies for metabolic disorders

Rhythm commences RM-493 Phase 2 trial in obesity

Rhythm commences RM-493 Phase 2 trial in obesity

Selective targeting of neurotransmitters may allow for new medication therapies for GI conditions

Selective targeting of neurotransmitters may allow for new medication therapies for GI conditions

Rhythm raises additional $8 million to complete Series B financing

Rhythm raises additional $8 million to complete Series B financing

Chronic electrical stimulation may help treat gastroparesis symptoms

Chronic electrical stimulation may help treat gastroparesis symptoms

Rhythm presents RM-131 Phase 1 clinical trial results for diabetic gastroparesis at ACG 2012

Rhythm presents RM-131 Phase 1 clinical trial results for diabetic gastroparesis at ACG 2012

Amylin, Alkermes announce results from BYDUREON clinical study on type 2 diabetes

Amylin, Alkermes announce results from BYDUREON clinical study on type 2 diabetes

European Commission grants marketing authorization for use of BYETTA with basal insulin

European Commission grants marketing authorization for use of BYETTA with basal insulin

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

BYETTA-basal insulin combination therapy receives EMA CHMP positive opinion

BYETTA-basal insulin combination therapy receives EMA CHMP positive opinion